HomeAUPH • NASDAQ
add
Aurinia Pharmaceuticals Inc
Previous close
$7.16
Day range
$7.11 - $7.23
Year range
$4.71 - $10.05
Market cap
1.03B USD
Avg Volume
1.47M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 57.19M | 37.83% |
Operating expense | 44.64M | 2.75% |
Net income | 722.00K | 106.28% |
Net profit margin | 1.26 | 104.55% |
Earnings per share | 0.01 | 112.50% |
EBITDA | 4.40M | 128.49% |
Effective tax rate | 51.15% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 330.33M | -5.73% |
Total assets | 523.53M | -4.62% |
Total liabilities | 158.91M | 1.47% |
Total equity | 364.62M | — |
Shares outstanding | 142.99M | — |
Price to book | 2.81 | — |
Return on assets | -0.21% | — |
Return on capital | -0.25% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | 722.00K | 106.28% |
Cash from operations | 15.84M | 660.62% |
Cash from investing | -38.62M | -588.69% |
Cash from financing | -8.27M | -825.70% |
Net change in cash | -31.05M | -325.72% |
Free cash flow | 17.50M | 219.46% |
About
Founded
2012
Headquarters
Website
Employees
300
